We're committed to finding solutions to some of the biggest unmet therapeutic needs in #dementia, #SCI & #MultipleSclerosis. One of our principles is to cultivate passion: remembering the science we do is exciting, yet keeping the urgency needed to solve these critical problems.
What a great week at #BIO2024 in San Diego! We've loved meeting potential new collaborators & investors, as well as raising awareness of our work developing novel CNS therapeutics. We'd like to thank the @NIH for the invitation to present & @IAmBiotech for hosting the event.
Today is the start of #BIO2024 - an annual #biotech conference organised by the @IAmBiotech. @NovoronBio will be participating in a range of activities across the event. If you're also attending & would like to organise a time to chat, please get in touch!
https://t.co/dHRNL6XsQ7
We're proud to call San Diego home & committed to engaging in the thriving #startup & #biotech community that exists here. As such, we loved having our CEO, Dr. Travis Stiles, participate in the recent @SDRegionalEDC panel discussion on how to successfully grow small businesses.
We're excited to share that our CEO, Travis Stiles, & Chief of Staff, Kristien Van Vlasselaer, will be attending the @biocom Annual Global Partnering & Investor Conference. If you're participating in this event & would like to know more about @NovoronBio, please get in touch.
Our CEO, Travis Stiles, will be at the #JPM2024 meeting in San Francisco this week. If you're also attending this event & would like to organize a time to chat about our work on #remyelination, #spinalcordinjury or #tauopathies, please get in touch & we'll happily arrange a time.
A big year for @NovoronBio is coming to an end! We want to take this opportunity to thank all of our employees & collaborators for their hard work & support this year. We hope that you have a safe, happy & relaxing holiday period with your families & loved ones. #HappyHolidays
Our CEO, @titostiles, recently had the pleasure of sitting down with @Healthunchaind from @VibeBio
to discuss the exciting work that we are doing to develop novel therapies for #MultipleSclerosis, #AlzheimersDisease & other neurological disorders.
https://t.co/iSjJa6wW2C
Our CEO, @titostiles, has been attending #MSMilan2023 to hear the latest #MultipleSclerosis research. He has also been working with @MStranslate to provide daily summaries for people living with #MS. You can watch the Day 1 summary in the video below. https://t.co/2QI1v10dvK
Having recently launched a research collaboration in Tasmania, it was great to meet @ScienceChiefAu at #BIO2023! Hearing more about the medical research ecosystem in Australia, we're excited about the research that we're doing & the potential to expand our presence "down under".
Thanks to Dr Rachel Kandel for this fantastic interview with our CEO, Dr Travis Stiles. The discussion captures much of the @NovoronBio journey: the past, the present and exciting news about our future! #neuroscience#biotech https://t.co/e4r3PvoOIA
Interesting research from @UHouston that may help us detect #AlzheimersDisease more quickly. As we progress towards finding novel therapies, the ability to deliver them in the earliest stages of the disease will be invaluable. @alzassociation https://t.co/GdevP3jhO8
As we celebrate the advancement in #SCI research, we want to congratulate @invivo_sci for finding ways to progress their #clinicaltrials despite the challenges faced by #biotech in recent years. https://t.co/DRrtmWy53o
Developing a therapy that promotes remyelination is a current goal of many #MultipleSclerosis researchers around the world. @MStranslate partner, Dr Travis Stiles, recently updated us on @NovoronBioโs work in this field. Learn more from him below. #MS https://t.co/WlA2jM1jXL
We rarely post about topics that aren't related to our work, but sometimes it is important to do so. We want to extend our thoughts & well-wishes to the people of #Ukraine. War is never the answer and we hope #peace can soon be restored in the region. #StandWithUkraine
Understanding what stops the repair of damaged myelin in #MultipleSclerosis, and overcoming it, is a big part of our work. The more puzzle pieces that are found, the quicker we can progress. Fantastic work by all involved in this #research at @EdinburghUni.
This #research from @EdinburghUni has provided more clues about why damaged myelin does not get repaired in #MultipleSclerosis. This understanding may help in the development of new remyelination therapies. #MS@mssocietyuk https://t.co/LRdxiFzafy
A @umichmedicine study has found that people living with a #SpinalCordInjury (SCI) have an almost 80% increased risk of developing #mentalhealth conditions, such as #depression & #anxiety. This further highlights the need to find novel solutions for SCI. https://t.co/TvNfzlkWfh
We are very excited about collaborating with Assistant Prof. Rauch on this important project! Stay tuned - as we will make sure we provide some updates as they become available! @rauch1jn#Alzheimers#neuroscience#biotech